280 related articles for article (PubMed ID: 30262597)
1. Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment.
Wolfson JA; Richman JS; Sun CL; Landier W; Leung K; Smith EP; O'Donnell M; Bhatia S
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1133-1141. PubMed ID: 30262597
[No Abstract] [Full Text] [Related]
2. Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.
Wolfson J; Sun CL; Wyatt L; Stock W; Bhatia S
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):312-320. PubMed ID: 28209594
[No Abstract] [Full Text] [Related]
3. A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
Ribera JM; Morgades M; Montesinos P; Tormo M; Martínez-Carballeira D; González-Campos J; Gil C; Barba P; García-Boyero R; Coll R; Pedreño M; Ribera J; Mercadal S; Vives S; Novo A; Genescà E; Hernández-Rivas JM; Bergua J; Amigo ML; Vall-Llovera F; Martínez-Sánchez P; Calbacho M; García-Cadenas I; Garcia-Guiñon A; Sánchez-Sánchez MJ; Cervera M; Feliu E; Orfao A;
Cancer Med; 2020 Apr; 9(7):2317-2329. PubMed ID: 32022463
[TBL] [Abstract][Full Text] [Related]
4. Sexual Dimorphism in Children and Adolescents With Acute Lymphoblastic Leukemia: Influence on Incidence and Survival.
Jaime-Pérez JC; Hernández-De Los Santos JA; Fernández LT; Padilla-Medina JR; Gómez-Almaguer D
J Pediatr Hematol Oncol; 2020 Jul; 42(5):e293-e298. PubMed ID: 31725540
[TBL] [Abstract][Full Text] [Related]
5. Results of therapy in children with acute lymphoblastic leukemia in over 50 years of experience in a single center in Poland.
Jatczak-Gaca A; Styczynski J; Koltan A; Debski R; Pogorzala M; Wysocki M
Leuk Lymphoma; 2015 Jul; 56(7):2212-4. PubMed ID: 25547656
[No Abstract] [Full Text] [Related]
6. The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study.
Gupta S; Pole JD; Baxter NN; Sutradhar R; Lau C; Nagamuthu C; Nathan PC
Cancer Med; 2019 May; 8(5):2095-2103. PubMed ID: 30912628
[TBL] [Abstract][Full Text] [Related]
7. Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia.
Muffly L; Yin J; Jacobson S; Wall A; Quiroz E; Advani AS; Luger SM; Tallman MS; Litzow MR; Foster MC; Erba HP; Appelbaum FR; Larson RA; Keegan THM; Stock W
Blood Adv; 2022 Jul; 6(14):4085-4092. PubMed ID: 35838753
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
Hangai M; Urayama KY; Tanaka J; Kato K; Nishiwaki S; Koh K; Noguchi M; Kato K; Yoshida N; Sato M; Goto H; Yuza Y; Hashii Y; Atsuta Y; Mizuta S; Kato M
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1597-1602. PubMed ID: 31002992
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G
J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094
[TBL] [Abstract][Full Text] [Related]
10. A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers.
Downs-Canner S; Shaw PH
J Pediatr Hematol Oncol; 2009 Dec; 31(12):927-9. PubMed ID: 19855302
[TBL] [Abstract][Full Text] [Related]
11. Association of clinical trial enrollment and survival using contemporary therapy for pediatric acute lymphoblastic leukemia.
Moke DJ; Oberley MJ; Bhojwani D; Parekh C; Orgel E
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28876513
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukemia in adolescents and young adults.
Ribera JM; Oriol A
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1033-42, vi. PubMed ID: 19825451
[TBL] [Abstract][Full Text] [Related]
13. Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
Burke MJ; Gossai N; Wagner JE; Smith AR; Bachanova V; Cao Q; MacMillan ML; Stefanski HS; Weisdorf DJ; Verneris MR
Biol Blood Marrow Transplant; 2013 Jan; 19(1):138-42. PubMed ID: 22960388
[TBL] [Abstract][Full Text] [Related]
14. Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.
Junghanns AS; Wittig S; Woehlecke C; Lehmann T; Arndt C; Gruhn B
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2221-8. PubMed ID: 26224397
[TBL] [Abstract][Full Text] [Related]
15. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.
Navarrete M; Rossi E; Brivio E; Carrillo JM; Bonilla M; Vasquez R; Peña A; Fu L; Martinez R; Espinoza CM; Lacayo LF; Rodriguez H; Batista R; Barr R; Howard SC; Ribeiro RC; Masera G; Biondi A; Conter V; Valsecchi MG
Pediatr Blood Cancer; 2014 May; 61(5):803-9. PubMed ID: 24376115
[TBL] [Abstract][Full Text] [Related]
16. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
17. Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia.
Orellana-Noia VM; Douvas MG
Curr Hematol Malig Rep; 2018 Apr; 13(2):100-108. PubMed ID: 29442287
[TBL] [Abstract][Full Text] [Related]
18. The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols.
Taskinen M; Oskarsson T; Levinsen M; Bottai M; Hellebostad M; Jonsson OG; Lähteenmäki P; Schmiegelow K; Heyman M
Pediatr Blood Cancer; 2017 Feb; 64(2):242-249. PubMed ID: 27748030
[TBL] [Abstract][Full Text] [Related]
19. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.
Shaw PH; Boyiadzis M; Tawbi H; Welsh A; Kemerer A; Davidson NE; Ritchey AK
Cancer; 2012 Jul; 118(14):3614-7. PubMed ID: 22213134
[TBL] [Abstract][Full Text] [Related]
20. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]